Products

Arine
Arine
Patient Engagement & Education
Arine's AI-powered platform identifies and supports members most at risk of medication-related problems before they experience negative health events, delivering tailored, proactive interventions to improve clinical outcomes and reduce costs of care across entire populations.
Arine Medication Intelligence
Arine
Pharmacology & Dosing AI
Arine leverages AI to provide a medication intelligence platform for comprehensive medication management, adverse event prediction, and optimization of drug regimens for health plans and providers, demonstrating significant improvements in health outcomes and cost reduction.

See all 2 products →

About Arine

Arine is an AI-powered medication optimization platform designed for health plans and providers, aiming to enhance patient outcomes and reduce healthcare costs. The platform integrates advanced analytics with deep clinical expertise to ensure that individuals receive the safest, most effective, and appropriate medications tailored to their unique and evolving health needs.

For physicians, Arine’s technology leverages AI to anticipate, enable, and optimize care for each member by providing multi-dimensional, culturally sensitive recommendations that encompass clinical, social, and behavioral parameters. It proactively identifies medication-related problems before they escalate into costly interventions, offering personalized recommendations and streamlining workflows for care teams to maximize efficiency. Arine’s solutions have demonstrated significant clinical and economic benefits, including over 10% in total cost savings and more than a 40% reduction in hospitalizations for health plan members.

Focus Areas

Medication management Medication optimization AI-driven medication intelligence Value-based care Reducing hospitalizations Cost savings Specialty pharmacy management HEDIS gaps in care Medicare Star Ratings Population health Clinical decision support Behavioral health

Business Intelligence

Key InvestorsTown Hall Ventures, Kaiser Permanente Ventures, 111 West Capital, MBX Capital, New Leaf Venture Partners, Katalyst Ventures, Visionaire Ventures, Magellan Health, Ascension Ventures, 1199SEIU Health Care Employees Pension Fund, SCAN Health Plan, MaC Venture Capital, Cocoon Ignite Ventures
PartnershipsSCAN Group (SCAN Health Plan), Priority Health, Blue Shield of California, Magellan Health
TechnologyAI-driven medication intelligence platform, AI-powered medication optimization platform, Clinical Learning and Analytic Response Engine (CLARA), cloud-native, leverages large and diverse datasets, predictive analytics, machine learning, GenAI

What Physicians Need to Know

Medication Optimization
Arine specializes in AI-powered medication optimization, ensuring patients receive the safest, most effective, and appropriate treatments. They address medication-related problems across populations, improving patient outcomes and reducing healthcare costs.
AI-Driven Intelligence
The platform leverages artificial intelligence, machine learning, and predictive analytics to integrate diverse datasets (clinical, behavioral, social determinants of health) and generate timely, personalized recommendations for interventions.
Value-Based Care & Cost Savings
Arine is designed for value-based care models, consistently delivering measurable value by reducing hospitalizations (>40%), decreasing total cost of care (>10%), and achieving significant cost savings per engaged member.
Population Health & Quality Improvement
They support population health initiatives by identifying high-risk patients, addressing HEDIS gaps in care, and improving Medicare Star Ratings through enhanced medication therapy management (MTM) and adherence.
Clinical Decision Support
Arine provides clinicians with data insights and actionable recommendations, automating tasks like generating patient care plans and prescriber communications to streamline workflows and improve efficiency.
Specialty Pharmacy & Behavioral Health
The company is expanding its capabilities in specialty pharmacy management and has demonstrated significant reductions (20-30%) in behavioral health costs through optimized medication strategies.
Physician Tip

For physicians, Arine stands out by providing timely, personalized, and actionable medication recommendations that are well-informed and include critical patient context, leading to high implementation rates (>50%) and reduced provider abrasion. The platform automates high-volume, low-complexity tasks, freeing up physicians to focus more on direct patient care. By integrating a comprehensive view of patients, including clinical, social, and behavioral data, Arine enables more holistic care, supports improved patient outcomes, and helps achieve crucial quality metrics like HEDIS and Medicare Star Ratings. It acts as a powerful clinical decision support tool, offering insights into care gaps and streamlining medication therapy management.

Arine's platform is designed for ease of integration with existing healthcare IT infrastructures, utilizing popular enterprise and analytics tools such as Microsoft Office 365, Google Analytics, and NetSuite. It integrates diverse data sets including clinical records, pharmacy data, clinical guidelines, medication data, and social determinants of health. Arine has also demonstrated successful partnerships, such as its integration with Gemini Health to incorporate real-time, patient-specific benefits data for optimizing medications and lowering prescription drug costs for health plans like Blue Shield of California.

Products by Arine

2 products in the directory

Arine
Arine
Patient Engagement & Education
Arine's AI-powered platform identifies and supports members most at risk of medication-related problems before they experience negative health events, delivering tailored, proactive interventions to improve clinical outcomes and reduce costs of care across entire populations.
Arine Medication Intelligence
Arine
Pharmacology & Dosing AI
Arine leverages AI to provide a medication intelligence platform for comprehensive medication management, adverse event prediction, and optimization of drug regimens for health plans and providers, demonstrating significant improvements in health outcomes and cost reduction.

What the Web Says

Arine is an AI-driven medication optimization platform that helps health plans and providers improve patient outcomes, reduce healthcare costs, and meet quality requirements by identifying and addressing medication-related problems. The platform integrates data science with clinical knowledge to provide insights, care plans, and tools for personalized patient care, automating tedious tasks for clinicians. Arine has demonstrated a positive impact on the cost of care within six months and quality performance metrics in less than a year, with a focus on health equity across diverse populations.

Overall: Positive

Strengths

  • Improves patient outcomes and satisfaction.
  • Reduces healthcare costs and hospitalizations.
  • Enhances team efficiency through automation and continuous reporting.
  • Provides personalized medication recommendations and care plans using AI and data analysis.
  • Offers flexible schedules and remote positions for employees.
  • Supportive leadership and a welcoming work environment.

Limitations

  • High workload and changing demands of projects for employees.
  • Stressful to maintain call volume for some roles.
  • Interview process can be perceived as lengthy and stiff.
  • Some employees note a lack of 401K match or significant bonuses.
  • Limited public reviews available on major platforms like G2, Glassdoor, and Capterra directly for Arine's product.

Based on reviews from: Slashdot, Elion Health, Buyersprove, SimplyHired, Reddit, SourceForge, Arine.io (Official Website), PitchBook

Last updated: 2026-08-05

Videos

News, demos, and interviews about Arine.

Loading videos...

Videos load interactively. If none appear, search YouTube for Arine →

View all on YouTube

Press & Coverage

PR Newswire
Arine Raises Series C to Scale AI-Driven Medication Optimization and Power Value-Based Outcomes
Arine, a leader in AI-driven medication intelligence, announced a $30 million Series C funding round led by Town Hall Ventures, bringing its total funding to $66 million. This funding will accelerate its mission to redefine medication management and expand into specialty pharmacy management.
2025-06
Arine
Arine Named to Inc. 5000 List of Fastest-Growing Companies for 2nd Year
For the second consecutive year, Arine has been recognized on Inc.'s prestigious Inc. 5000 list of fastest-growing private companies, ranking No. 432 overall and No. 16 in the AI and Data category. This highlights their significant growth and impact in addressing medication mismanagement in healthcare.
2025-08
Arine
Arine Named 2025 Technology Pioneer by the World Economic Forum
Arine, the AI-powered medication intelligence platform, has been selected as a 2025 Technology Pioneer by the World Economic Forum for its groundbreaking innovation in optimizing medication and reducing healthcare costs. This recognition allows Arine to contribute to global discussions on the future of healthcare and AI.
2025-08
Pulse 2.0
Arine: $30 Million Series C Raised For AI-Based Medication Optimization Platform
Arine secured $30 million in Series C funding, led by Town Hall Ventures, to further scale its AI-based medication optimization platform. The company aims to expand specialty pharmacy management and accelerate AI innovation to automate tasks and personalize medication therapy.
2025-07
The SaaS News
Arine Secures $30 Million in Series C
Arine, an AI-driven medication optimization platform based in San Francisco, raised $30 million in Series C funding, bringing its total funding to $66 million. The funds will be used to expand specialty pharmacy management, enhance AI automation, and deepen data integration for personalized medication therapy.
2025-06
Arine
MDX Hawaii and Arine Partner to Enhance Medication Optimization, Improve Health Outcomes, and Reduce Costs
MDX Hawaii has partnered with Arine to leverage its AI-powered platform for medication optimization, aiming to improve patient care, health outcomes, and reduce costs. This collaboration highlights Arine's ability to deliver meaningful impact for health plan partners.
2025-04
Arine
What is Fueling Arine's Growth? We're Solving a Massive, Urgent Healthcare Challenge
Arine's continued growth is driven by its mission to solve medication mismanagement, a systemic crisis costing the U.S. healthcare system billions annually and leading to preventable deaths. Their AI-driven platform delivers significant reductions in hospitalizations and total cost of care.
2025-08
PR Newswire
Inc. 5000 Recognizes Arine as One of America's Fastest-Growing Private Companies
Arine was ranked No. 236 on the 2024 Inc. 5000 list and 5th in the AI category, demonstrating its pivotal role in optimizing medication therapy and delivering value-based care. Their solutions have led to a 40% reduction in hospitalizations and a 10% decrease in total cost of care.
2024-08

Frequently Asked Questions

Arine provides an AI-driven medication intelligence platform that optimizes medication therapy by analyzing clinical, behavioral, and social data to identify patients at risk of medication-related problems. The platform delivers personalized recommendations and streamlines workflows for care teams, aiming to improve health outcomes and reduce costs.
Arine's platform is specifically designed to support value-based care by delivering measurable outcomes such as over 10% reduction in total cost of care and 40% reduction in hospitalizations. It helps health plans achieve 4-5 Star Ratings for quality and MTM measures and addresses HEDIS gaps in care through proactive, tailored interventions.
Arine offers a suite of solutions including LUMINATE for high-risk patient management, RESONATE for prescriber analytics, and ELEVATE for quality improvement and Medication Therapy Management (MTM). These modules work together to proactively identify and resolve medication-related issues across diverse populations.
Arine's AI-powered platform integrates clinical, behavioral, and social data to provide comprehensive medication optimization, which includes addressing behavioral health concerns. It has demonstrated success in reducing behavioral health polypharmacy and increasing adherence to behavioral health medications.
Arine prioritizes the security of personal information, encrypting data both in transit and at rest, and employs security measures to protect against unauthorized access or disclosure. The platform is HIPAA compliant, ensuring the protection of sensitive patient data.
Arine operates on a subscription-based revenue model, where healthcare organizations pay for access to its AI-powered medication management platform and associated services. While specific pricing details are not publicly disclosed, the model is designed to deliver immediate ROI and cost savings, aligning with clients' financial goals.
Arine offers customer support via email and phone, and its platform is designed for seamless integration and ongoing value. They partner with numerous health plans and risk-bearing providers, including national and regional organizations, to deliver tailored medication intelligence solutions.
Founded in 2017, Arine has demonstrated strong company stability, having raised $66 million in total funding, including a $30 million Series C round in June 2025. The company boasts a 100% client retention rate and significant revenue growth, indicating a robust market presence and customer satisfaction.

Investors

Who's funded Arine.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.